Lyon Civil Hospitals is using robotics in its CLARA (Lyon Auvergne Rhône-Alpes Cancer cluster) program as a component in a method for treating small cancer tumors. Early diagnosis of smaller tumors is possible through screening biological tests and medical imaging. The CLARA project introduces a new concept where Adept robots will be employed to automatically locate a treatment probe close to a tumor using an innovative three-dimensional navigation robot that is guided by a tracking sensor implanted in the body. The goal is to demonstrate that an Adept Viper 6-axis robot will ensure perfect positioning of a treatment probe in a tumor for both percutaneous and laparoscopic surgical approaches.
The success of this project relies on an experienced surgical and radiological academic team from Université Lyon 1 (UCBL), whose research is oriented on focal therapies with experience in engineering and experimental surgery.
“We believe that the instrument designed will have a strong impact on both therapeutic and economic ground,” said Professor Marc Colombel, Head of Surgical Robotics Developments at Lyon Civil Hospitals and Professor at Université Lyon 1.
Said Rush LaSelle, director of worldwide sales and marketing for Adept Technology, Inc., “This opportunity allows Adept to accelerate the development and deployment of safer and more collaborative robotic technologies, further enabling mechatronics to assist the medical community in improving people’s lives.”
Adept Technology, Inc.